Cargando…

ICOS Regulates the Generation and Function of Human CD4(+) Treg in a CTLA-4 Dependent Manner

Inducible co-stimulator (ICOS) is a member of CD28/Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) family and broadly expressed in activated CD4(+) T cells and induced regulatory CD4(+) T cells (CD4(+) iTreg). ICOS-related signal pathway could be activated by the interaction between ICOS and its ligand (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Jian, Chan, Ping-Lung, Liu, Yinping, Qin, Gang, Xiang, Zheng, Lam, Kwok-Tai, Lewis, David B., Lau, Yu-Lung, Tu, Wenwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846688/ https://www.ncbi.nlm.nih.gov/pubmed/24312642 http://dx.doi.org/10.1371/journal.pone.0082203

Ejemplares similares

TLR5 Signaling Enhances the Proliferation of Human Allogeneic CD40-Activated B Cell Induced CD4(hi)CD25(+) Regulatory T Cells
por: Chan, Ping-Lung, et al.
Publicado: (2013)

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
por: Bouwhuis, Marna G., et al.
Publicado: (2009)

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2016)

ICOS(+) Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2020)

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
por: Fan, Xiaozhou, et al.
Publicado: (2014)

Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4
por: Botturi, Karine, et al.
Publicado: (2011)

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2017)

Dendritic and T Cell Response to Influenza is Normal in the Patients with X-Linked Agammaglobulinemia
por: Liu, Yinping, et al.
Publicado: (2012)

Corrigendum: ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2021)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Induced Treg Cells Augment the Th17-Mediated Intestinal Inflammatory Response in a CTLA4-Dependent Manner
por: Watanabe, Nobumasa, et al.
Publicado: (2016)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Treg and CTLA-4: Two intertwining pathways to immune tolerance
por: Walker, Lucy S.K.
Publicado: (2013)

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019)

The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized mice
por: Tu, Wenwei, et al.
Publicado: (2011)

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumors
por: Zappasodi, Roberta, et al.
Publicado: (2021)

Low frequency of CD4(+)CD25(+ )Treg in SLE patients: a heritable trait associated with CTLA4 and TGFβ gene variants
por: Barreto, Marta, et al.
Publicado: (2009)

Protective Effector Memory CD4 T Cells Depend on ICOS for Survival
por: Moore, Tamson V., et al.
Publicado: (2011)

Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study
por: Tsang, Tim K., et al.
Publicado: (2022)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Liu, Hsin-Yu, et al.
Publicado: (2021)

The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cells
por: Mahajan, Simmi, et al.
Publicado: (2007)

CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function
por: Chen, Yang, et al.
Publicado: (2018)

The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy
por: John, Peter, et al.
Publicado: (2022)

Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation
por: Burnett, Deborah L, et al.
Publicado: (2017)

Influenza Virus-Induced Lung Inflammation Was Modulated by Cigarette Smoke Exposure in Mice
por: Han, Yan, et al.
Publicado: (2014)

The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice
por: Zheng, Jian, et al.
Publicado: (2015)

Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8(+) T cell immunity to reject ‘cold’ tumors
por: Semmrich, Monika, et al.
Publicado: (2022)

In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4(+)CD25(−) Cells in Mice
por: Arazi, Arnon, et al.
Publicado: (2009)

ICOS is required for the generation of both central and effector CD4(+) memory T‐cell populations following acute bacterial infection
por: Marriott, Clare L., et al.
Publicado: (2015)

S-nitrosoglutathione modulates CXCR4 and ICOS expression
por: Yamamoto, Yoshihiko, et al.
Publicado: (2006)

Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide
por: Lee, Woo-Sung, et al.
Publicado: (2023)

CD152 (CTLA-4) Determines CD4 T Cell Migration In Vitro and In Vivo
por: Knieke, Karin, et al.
Publicado: (2009)

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
por: Yap, Timothy A., et al.
Publicado: (2022)

CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
por: Herman, Ann E., et al.
Publicado: (2004)

CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
por: Pilat, Nina, et al.
Publicado: (2018)

TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion
por: Sharma, Naveen, et al.
Publicado: (2019)

Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4(+)Foxp3(+) Treg Induction
por: Massalska, Magdalena, et al.
Publicado: (2022)

Hepatitis B envelope antigen increases Tregs by converting CD4+CD25(-) T cells into CD4(+)CD25(+)Foxp3(+) Tregs
por: Tang, Rui, et al.
Publicado: (2020)

Circulating CD4(+) Treg, CD8(+) Treg, and CD3(+) γδ T Cell Subpopulations in Ovarian Cancer
por: Li, Rong, et al.
Publicado: (2023)

CD4(+)T Cell Subset Profiling in Biliary Atresia Reveals ICOS(−) Regulatory T Cells as a Favorable Prognostic Factor
por: Zhang, Shuhao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7eo8ufmlbp48lgs0l9l9e5d379